|
|
|
|
| OVERVIEW |
Schizophrenia is a
debilitating psychiatric disorder that affects 1% of adult Americans.
Often striking without warning in the late teens or early twenties,
its symptoms include visual and auditory hallucinations, psychotic
outbreaks, bizarre or disordered thinking, as well as depression
and social withdrawal. The childhood-onset form of the disorder
is similar to the adult-onset form in many ways, but it is more
severe.
Childhood onset schizophrenia affects about 1 child in 40,000, compared
to 1 in 100 in adults. Children with schizophrenia experience difficulty
in managing everyday life. They share with their adult counterparts
hallucinations, delusions, social withdrawal, flattened emotions,
increased risk of suicide and loss of social and personal care skills.
They may also share some symptoms with—and be mistaken for—children
who suffer from autism or other pervasive developmental disabilities,
which affect about 1 in 500 children. Children with schizophrenia
tend to be harder to treat and have a worse prognosis than adult-onset
schizophrenia patients.
|
|
DIAGNOSIS |
While schizophrenia
generally begins as an acute psychotic episode in young adults,
it appears to emerge more gradually in children. The appearance
of the disorder is often preceded by developmental disturbances,
such as lags in motor and speech/language development. These developmental
problems can often be associated with more distinct brain abnormalities.
The diagnostic criteria are the
same as for adults (read
more about schizophrenia), except that symptoms appear
prior to age 12. Children with schizophrenia frequently see or
hear things that don't really exist, and often hold paranoid
and bizarre beliefs. These symptoms may be accompanied by attention
problems, impaired memory and reasoning, speech impairments, inappropriate,
or flattened affect, poor social skills, and depressed mood. Misdiagnosis
of schizophrenia in children is common. Symptoms are prevalent
in the child's life and are not limited to specific situations.
Children with schizophrenia tend to be cut off from normal relationships
and are unlikely to show any interest in friendships with others.
|
| CAUSES |
It is commonly held
that both genetic and environmental factors contribute to the development
of schizophrenia Although it's unclear whether it has a single or
multiple underlying causes, evidence strongly supports the theory
that it is a neurodevelopmental disease likely involving a genetic
predisposition, a prenatal insult to the developing brain and stressful
life events. Recent research has shown that children share with
adults many of the same abnormal brain structural, physiological
and neuropsychological features associated with schizophrenia. Children
seem to have more severe cases than adults, with more pronounced
neurological abnormalities.
|
| CURRENT
RESEARCH |
| Since 1992 researchers
at the National Institute of Mental Health in Bethesda have scanned
over 1,000 children and adolescents with high-resolution brain
MRIs. What makes this study unique is the fact that these children
return to the clinic to be re-scanned every 2 years. Many children
are now receiving their 5th scan, and have grown up in the meantime,
leaving a remarkable time-lapse movie as record of how their brain
has developed. The resulting treasure-chest of brain scans charts
brain growth in unprecedented detail. Among those patients scanned
at NIMH were 40 adolescents with early-onset schizophrenia (EOS),
who were scanned repeatedly as their disorder developed. These
patients had detailed cognitive and clinical evaluations; they
satisfied DSM-III-R/DSM-IV criteria for diagnosis of schizophrenia
before the age of 12. Since their symptoms are continuous with
the adult disorder, their brain scans and repeated neuropsychiatric
tests hold key information on how schizophrenia develops in the
teenage years.
In a longitudinal brain imaging study of adolescents, MRI scans
revealed fluid filled cavities in the middle of the brain enlarging
abnormally between ages 14 and 18 in teens with early onset schizophrenia,
suggesting a shrinkage in brain tissue volume. These children
lost four times as much gray matter, neurons and their branch-like
extensions, in their frontal lobes as normal teens. This gray
matter loss engulfs the brain in a progressive wave from back
to front over 5 years, beginning in rear structures involved in
attention and perception, eventually spreading to frontal areas
responsible for organizing, planning, and other "executive"
functions impaired in schizophrenia. Since losses in the rear
areas are influenced mostly by environmental factors, the researchers
suggest that some non-genetic trigger contributes to the onset
and initial progression of the illness. The final loss pattern
is consistent with that seen in adult schizophrenia. Adult-onset
patients' brains may have undergone similar changes when they
were teens that went unnoticed because symptoms had not yet emerged,
suggest the researchers.
|
 |
| RESEARCH
AT LONI |
In recent
collaborations with the NIMH team, we have aimed to develop extremely
sensitive methods to map changes in the developing brain. The goal
is to visualize where the brain is growing fastest, measuring local
growth rates and their statistics, and revealing where gray matter
or other types of tissue are lost. By combining and comparing data
from multiple subjects, we have created detailed color-coded maps
to uncover where and how fast these changes occur, and where the
brain changes most prominently in disease.
 |
| |
Mapping
Brain Changes in Schizophrenia.
Derived from high-resolution
magnetic resonance images (MRI scans), the above images
were created after repeatedly scanning 12 schizophrenia
subjects over five years, and comparing them with matched
12 healthy controls, scanned at the same ages and intervals.
Severe loss of gray matter is indicated by red and pink
colors, while stable regions are in blue. STG denotes the
superior temporal gyrus, and DLPFC denotes the dorsolateral
prefrontal cortex. (Reprinted with permission from Thompson
PM et al., Proceedings of the National Academy of Sciences
of the USA, 98[20]:11650-11655) |
|
In studying the schizophrenic patients, we were stunned to see
a spreading wave of tissue loss that began in a small region of
the brain, the parietal cortices (see accompanying image, top
row, red colors). This deficit pattern, which we recently reported
in the Proceedings of the National Academy of Sciences, moved
across the brain like a forest fire. It destroyed more tissue
as the disease progressed (red colors, bottom row), eventually
engulfing the rest of the cortex after a period of 5 years. The
3D maps are color coded to show different degrees of change, revealing
where gray matter is significantly reduced in disease.
|
| Methods |
| At each scan, 12 schizophrenic
patients were compared with 12 healthy controls matched for age,
gender, and demographics. In each scan, a measure of the local quantity
of gray matter was made at each point on the cerebral cortex, and
changes were mapped in both patients and controls. |
| |
| Results |
At their first scan
(an average of 1.5 years after initial diagnosis), patients showed
a 10% gray matter deficit in a small region of the cortex. This
deficit, observed at the age of 13, was initially confined to
parietal brain regions involved in spatial association. Over the
5 succeeding years, this brain tissue loss swept forward into
sensory and motor regions, and by the age of 18, into dorsolateral
prefrontal and temporal cortices, which were not initially affected.
This pattern was replicated in independent groups of male and
female patients. Each showed a similar pattern of spreading deficits,
reaching a 20%-25% average loss. Overall, regions of loss corresponded
with the impairments in neuromotor, auditory, visual search, and
frontal executive functions that characterize schizophrenia. The
frontal eye fields lost tissue fastest, at about 5 percent per
year, perhaps consistent with the eye-tracking and smooth eye
pursuit deficits often reported in patients. |
| |
| Clinical Symptoms |
This dynamic wave
of brain tissue loss also correlated with worsening psychotic
symptoms and mirrored the progression of neurological and cognitive
deficits associated with the disorder. Specifically, patients
with fastest loss in temporal cortices had worst positive symptoms
(including hallucinations and delusions). Since temporal loss
rates were a good predictor of positive symptoms at follow-up,
future studies in larger samples will be able to assess whether
these losses link more specifically with auditory rather than
visual hallucinations. In addition, gray matter loss in the frontal
cortices correlated with increased negative symptoms (such as
lack of emotional responses and poverty of speech). The resulting
deficits are consistent with the physiological hypothesis that
negative symptoms of schizophrenia may partly derive from reduced
dopaminergic activity in frontal cortices. We are currently developing
digital mapping methods to isolate which specific frontal deficits
(e.g., dorsolateral prefrontal, orbitofrontal) link most tightly
with negative symptoms. |
| |
| Medication Effects |
| We also wanted to address
the possibility that drug treatment may have induced these patterns
of gray matter loss in the schizophrenic patients. So we also mapped
10 IQ-matched, serially imaged non-schizophrenic subjects, who received
identical medication to the patients (primarily for control of chronic
mood disorders and aggressive outbursts). While the non-schizophrenic
group did show some subtle but significant tissue loss, this was
much less marked than for the schizophrenics, and was restricted
to superior frontal cortices. No temporal lobe or pervasive frontal
deficits were observed in the medication controls, suggesting that
the wave of disease progression may be specific to schizophrenia,
regardless of medication, and also regardless of gender or IQ. |
| |
| Genetics |
| With the recent discovery
of several candidate genes that affect individual risk for schizophrenia,
specific genetic factors may soon be implicated in causing this
deficit pattern, or at least in increasing susceptibility to the
illness. Relatives who are genetically closer to a schizophrenic
patient are more likely to develop the disorder themselves, and
there is considerable interest in determining individual relatives'
risk for the disease, as well as understanding its genetic transmission.
Recently, we developed a technique to visualize genetic influences
on brain structure. This technique determines which aspects of brain
structure we inherit from our parents, which are therefore similar
among family members. This genetic brain mapping approach also links
structure features that can be measured from a brain scan with behavioral
traits such as IQ, and even genetically transmitted deficits. To
examine the genetic transmission of deficits in schizophrenia, we
recently measured differences in cortical gray matter between monozygotic
(MZ) twins discordant for schizophrenia. These twins are genetically
identical, but only one twin per pair has the disorder. Since only
48% of the MZ twins of a patient ever develop schizophrenia, genes
are not all-important in producing the disease. In the identical
twins we examined, the schizophrenic member of each pair showed
statistically significant gray matter reductions (between 5-8%)
in superior parietal cortices and dorsolateral prefrontal cortices,
and in the superior temporal gyrus of the left hemisphere. There
were no significant differences between the discordant co-twins
in primary somatosensory or primary motor areas. Since the MZ twins
were identical genetically, the early loss of parietal cortex in
the EOS patients suggests an environmental rather than a genetic
origin for the disease. In the frontal and temporal regions, however,
where loss occurred relatively late in the EOS patients, deficits
were |
| |
| Future Research |
| New imaging methods,
including those linking brain deficits with specific risk genes,
are likely to be at the forefront in discovering the triggers of
schizophrenia. Imaging methods also show promise for early detection
of the disease, especially in relatives who are at genetic risk.
Patients may then be treated at the earliest possible opportunity,
before the ravages of the disease have set in. |
 |
|
 |
|
|
| IN THIS SECTION: |
 |
|
|
|
|
|